Sharma, S <br/><br/>
Demographic and HIV-specific characteristics of participants enrolled in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.  [electronic resource] 

 -  HIV medicine  Apr 2015 
 - 30-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-1293 
<br/><br/><label>Standard No.: </label>10.1111/hiv.12231  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Retroviral Agents--therapeutic use<br/>Antiretroviral Therapy, Highly Active--methods<br/>CD4 Lymphocyte Count<br/>Cohort Studies<br/>Demography<br/>Female<br/>HIV Infections--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Time Factors<br/>Treatment Outcome